Swine Mycoplasma Vaccine Market, Global Outlook and Forecast 2024-2030

Page 1


Report Overview

The global key manufacturers of Swine Mycoplasma Vaccine include Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Pulike Biotech and Qilu Animal Health Products, etc. in 2023, the global top five players have a share approximately % in terms of revenue.Swine mycoplasma vaccine is a type of vaccine that is designed to prevent mycoplasma infections in pigs. Mycoplasmas are bacteria that can cause a variety of respiratory and reproductive diseases in pigs, such as enzootic pneumonia, arthritis, and urinary tract infections.

Market Segmentation

Swine Mycoplasma Vaccine Market is split by Type and by Application. For the period 2018-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market by Type:

•Inactivated Vaccines

•Live Vaccines

Market by Application:

•Piglets

•Adult Pigs

Market Key Players

•Zoetis

•Boehringer Ingelheim

•Jinhe Biotechnology

•Merck

•HIPRA

•Ceva Sant? Animale

•Harbin Pharmaceutical Group

•Pulike Biotech

•Qilu Animal Health Products

•Wuhan Keqian Biology

•Guangdong Winsun BioPharmaceutical

Market Region

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Swine Mycoplasma Vaccine Market, Global Outlook and Forecast 2024-2030 by MarketResearch - Issuu